Xarelto: new oral anticoagulantBayer's Xarelto (rivaroxaban 10 mg tablets) is the second new oral anticoagulant to be marketed in Canada this year, following the introduction of Boehringer Ingelheim's Pradax (dabigatran etexilate 75 mg and 110 mg capsules) in July. Insect repellents: new patient guidelines Liberals promise catastrophic drug plan New Listeria guidelines New Natural Health Products database now available New guidelines: bacterial vaginosis in pregnancy Awards predict top sellers Study finds impact of drug advertising exaggerated Valcyte: new dosage form Seroquel/Seroquel XR: expanded indication Shoppers launches new beauty concept A questionable mix Pharmacist-led study finds various juices. First Previous 2020 2021 2022 2023 2024 Next Last
